Amiloride may impede PCa tumor growth by inhibiting the urokinase-type plasminogen activator (uPA), a serine protease mediator of cell migration, invasion and metastasis and well‐known marker of poor prognosis in various human cancers, including PCa [38, 39]. Here, PLAU is linked to neoplasm.